Home NDC 11704-106 ATROPEN Auto-Injector
Product NDC 11704-106
11-digit product format 117040106
Labeler code 11704
Product ID 11704-106_f1736bb6-219c-48dd-969d-f26f6fbad350
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name atropine
Dosage form INJECTION
Route INTRAMUSCULAR
Labeler Meridian Medical Technologies LLC
Application NDA017106
Marketing category NDA
Marketing start 2003-06-19
Substance ATROPINE
Active strength 2 mg/.7mL
Pharmacologic classes Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017106-001 ATROPEN ATROPINE EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 N017106-002 ATROPEN ATROPINE EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 N017106-003 ATROPEN ATROPINE EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 N017106-004 ATROPEN ATROPINE EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N017106-001 ATROPEN EQ 2MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N017106-002 ATROPEN EQ 1MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N017106-003 ATROPEN EQ 0.5MG SULFATE/0.7ML SOLUTION / INTRAMUSCULAR RLD 2003-06-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N017106-004 ATROPEN EQ 0.25MG SULFATE/0.3ML SOLUTION / INTRAMUSCULAR RLD 2004-09-17 d8e5a09893c0…
Additional Listing Data#
Finished product Yes
Brand name base ATROPEN Auto-Injector
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ATROPINE 2 mg/.7mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7C0697DR9I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1190536 Internal RxNorm lookup 1190538 Internal RxNorm lookup 1190540 Internal RxNorm lookup 1190542 Internal RxNorm lookup 1190608 Internal RxNorm lookup 1190611 Internal RxNorm lookup 1190614 Internal RxNorm lookup 1190620 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 11704-106-01 ATROPEN Auto-Injector 0.7 mL in 1 SYRINGE, PLASTIC INJECTION 0.7 12
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 11704-106 ATROPEN AUTO-INJECTOR (ATROPINE) INJECTION [MERIDIAN MEDICAL TECHNOLOGIES LLC] 12 Current NDC, Legacy NDC, 1 package rows 20220921_e2d4307d-da8f-49f5-aac0-02355dd9ffb7.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 11704-106-01 11704010601 .7 mL in 1 SYRINGE, PLASTIC (11704-106-01) 2003-06-19 0000-00-00 No No Current